Location History:
- Rotrkeuz, CH (2015)
- Adliswil, CH (2017)
- Muri bei Bern, CH (2023)
- Zug, CH (2023)
- Rotkreuz, CH (2012 - 2024)
Company Filing History:
Years Active: 2012-2024
Title: Michael Glauser: Innovator in Microfluidics
Introduction
Michael Glauser is a prominent inventor based in Rotkreuz, Switzerland. He holds a total of nine patents, showcasing his significant contributions to the field of microfluidics and laboratory systems. His innovative work has advanced the capabilities of thermal incubation and separation methods in laboratory settings.
Latest Patents
One of Glauser's latest patents is a sealable microfluidic chip for thermocycling. This invention relates to the reversible sealing of a microfluidic chip used for thermal incubation of an aqueous sample suspected to contain a target nucleic acid. The chip features a flow channel and multiple reaction compartments, allowing for the introduction of the sample and a displacement fluid through an inlet port that can be sealed with a sealing agent having a melting point above room temperature. Another notable patent is a laboratory system and method for separating interfering substances contained in test samples. This system comprises separation vessels with solid surfaces and capturing molecules that are immobilized on these surfaces. The capturing molecules are designed to bind interfering substances in laboratory tests across various analytical methods.
Career Highlights
Throughout his career, Michael Glauser has worked with renowned companies such as Roche Diagnostics Operations, Inc. and Roche Molecular Systems, Inc. His experience in these organizations has contributed to his expertise in developing innovative laboratory solutions.
Collaborations
Glauser has collaborated with notable colleagues, including Oliver Gutmann and Edwin Oosterbroek. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Michael Glauser's contributions to microfluidics and laboratory systems have made a significant impact on the scientific community. His innovative patents and collaborations reflect his dedication to advancing technology in laboratory practices.